| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Stocks Mutual Funds > Commodity Futures Trading Using Fuzzy Logic and Market Synchronization Clues, PART 2 |
|
Top Articles - Commodity Futures Trading Using Fuzzy Logic and Market Synchronization Clues, PART 2
There's nothing better than fuzzy logic for determining when a commodity market has begun a n According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ew trend and is starting to synchronize. Read on to find out exactly what this is all about.. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in . Observation From Trading Notes: "After an e-mini futures top forms over 1-2 days with big lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. contracts and multiple tops, look for the last rally to labor up all day AFTER a sharp and f here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ast down opening with poor A-D line. Key: It will spike or touch the 5 min chart channel one d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ast time. This is the best place to short." This is another familiar e-mini futures pattern. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc In this case it's a big set up for a big move. There are always some kind of preparations fo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi r a big move. Your job is to identify them. These are patterns that will repeat every 5-10 da nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ys or so. The anemic rally is the key. It’s like the market is running out of gas and getting and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ tired. That last stretch to tap the channel in a weakened state is an e-mini short trade you ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi should jump on. It is a "high probability" trade. If you stalk this trade, focused and patie ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nt, you will find your share of these kinds of set ups. Notice they are not rigid, computer dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod system type patterns. Making sense of them requires the fuzzy logic of the brain that is look cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ing at many indications and patterns at once. You will get to the point where you can simply tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen feel you’ve been there before in a general way and know that this means a short sale. There’ t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel no computer program that can do the same integration at this time. There will be someday, bu ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t for now the extraordinary commodity futures traders, the superstars who earn $millions+ a y y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ear, are mostly discretionary (fuzzy logic) people using computers to do the raw number crunc . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hing - the grunt work. Good Trading! There is substantial risk of loss trading futures and elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip options and may not be suitable for all types of investors. Only risk capital should be used tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Get The Sale By Not Over-Selling How to Start Making Money With Sales Letters Wall Street to Main Street: News, Views and Commentary: December 5, 2005
|